Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Dates for the review of this are yet to be set and are likely to be at least a year away
In the U.S., CMS guidance from March 2024 allows Medicare Part D coverage of AOMs with medically accepted indications, such as diabetes or reducing the risk of major adverse cardiovascular events in patients with established cardiovascular disease
And depending on the specific medication, people might also experience headaches, insomnia, dizziness, tingling sensations, anxiety, and irritability
Both approaches are producing results that seemed impossible just a decade ago
US$ 28.41
US$ 29.22
US$ 26.61
